Form 4: Aveanna Healthcare CFO Sells Over 11,000 Shares Under Pre-Arranged Trading Plan
Insider Transaction Report
Aveanna Healthcare Holdings, Inc.'s Chief Financial Officer, Matthew Buckhalter, sold 11,188 shares of common stock for approximately $5.72 per share on June 10, 2025, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Matthew Buckhalter, the Chief Financial Officer of Aveanna Healthcare Holdings, Inc. (AVAH), reported the sale of company common stock.
- The transaction occurred on June 10, 2025.
- A total of 11,188 shares of common stock, with a par value of $0.01 per share, were disposed of.
- The shares were sold at a weighted-average price of $5.7167 per share, with trades ranging from $5.70 to $5.75.
- The sale was executed pursuant to a Rule 10b5-1(c) contract, instruction, or written plan for the purchase or sale of equity securities.
- Following this transaction, Mr. Buckhalter beneficially owns 490,057 shares of Aveanna Healthcare Holdings, Inc. common stock.
Sentiment
Score: 5
Explanation: The document reports a factual insider stock sale. While insider selling can sometimes be perceived negatively, the transaction was conducted under a Rule 10b5-1 plan, indicating a pre-scheduled sale rather than a discretionary one based on new information, thus making the sentiment neutral.
Positives
- The transaction was conducted under a Rule 10b5-1(c) plan, indicating a pre-scheduled sale and not necessarily a reaction to recent company performance or material non-public information, which enhances transparency and compliance.
Negatives
- Chief Financial Officer Matthew Buckhalter sold 11,188 shares of company common stock, which represents a reduction in his direct holdings.
Risks
- Potential investor perception concerns regarding insider selling, although this is largely mitigated by the disclosure that the transaction was part of a pre-arranged Rule 10b5-1 plan.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Policy/Compliance | The reported transaction was executed under a Rule 10b5-1(c) plan, which allows insiders to set up pre-arranged trading plans to avoid accusations of trading on material non-public information. | 06/10/2025 | Enhances transparency and compliance with insider trading regulations, mitigating potential negative perceptions of insider sales by demonstrating a pre-planned, non-discretionary transaction. |
Stakeholder Impact
- Shareholders: The disclosure of an insider stock sale, even under a 10b5-1 plan, provides transparency regarding management's stock holdings and trading activities.
Key Dates
| Date | Description |
|---|---|
| 06/10/2025 | Date of earliest transaction (sale of common stock by Matthew Buckhalter). |
| 06/11/2025 | Date the Form 4 was signed by the Attorney-in-Fact. |
Keywords
Aveanna Healthcare, AVAH, Form 4, Insider Trading, Stock Sale, CFO, Matthew Buckhalter, Rule 10b5-1, Healthcare Services
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.